| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 4,022 | 4,648 | 6,876 | 6,902 | | Selling General and Administrative | 2,024 | 2,532 | 2,055 | 2,005 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,046) | (7,180) | (8,931) | (8,907) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,685) | 649 | 172 | 389 | | Earnings Before Interest And Taxes | (7,731) | (6,531) | (8,759) | (8,518) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (7,731) | (6,531) | (8,759) | (8,518) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,731) | (6,531) | (8,759) | (8,518) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,731) | (6,531) | (8,759) | (8,518) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,731) | ($6,531) | ($8,759) | ($8,518) |
|
0.26% Nasdaq 
0.08 (3.49%) 
Income Statement
